Amylin in bone conservation current evidence and hypothetical Considerations.

Amylin, a 37-amino-acid long single-chain polypeptide, is structurally homologous to calcitonin and calcitonin gene-related peptide (CGRP). The peptide is secreted from pancreatic beta cells and is thought to have an anti-insulin action. Here, we review the recently described effects of amylin on ca...

Full description

Bibliographic Details
Main Authors: Zaidi, M, Shankar, V, Huang, C, Pazianas, M, Bloom, SR
Format: Journal article
Language:English
Published: 1993
_version_ 1797088610481078272
author Zaidi, M
Shankar, V
Huang, C
Pazianas, M
Bloom, SR
author_facet Zaidi, M
Shankar, V
Huang, C
Pazianas, M
Bloom, SR
author_sort Zaidi, M
collection OXFORD
description Amylin, a 37-amino-acid long single-chain polypeptide, is structurally homologous to calcitonin and calcitonin gene-related peptide (CGRP). The peptide is secreted from pancreatic beta cells and is thought to have an anti-insulin action. Here, we review the recently described effects of amylin on calcium homeostasis and discuss its possible role in bone conservation. Amylin is a potent hypocalcemic and antiresorptive peptide. Studies using isolated osteoclasts have revealed that amylin inhibits cell motility (Q effect), without affecting cell spread area or elevating cytosolic [Ca(2+)]. Thus, amylin action is similar to that of calcitonin, but lower in potency. Lower circulating concentrations of amylin in type-1 diabetes may cause the bone loss associated with this condition.
first_indexed 2024-03-07T02:52:34Z
format Journal article
id oxford-uuid:ae2c6270-c055-494f-9741-996c7ad5f586
institution University of Oxford
language English
last_indexed 2024-03-07T02:52:34Z
publishDate 1993
record_format dspace
spelling oxford-uuid:ae2c6270-c055-494f-9741-996c7ad5f5862022-03-27T03:40:49ZAmylin in bone conservation current evidence and hypothetical Considerations.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ae2c6270-c055-494f-9741-996c7ad5f586EnglishSymplectic Elements at Oxford1993Zaidi, MShankar, VHuang, CPazianas, MBloom, SRAmylin, a 37-amino-acid long single-chain polypeptide, is structurally homologous to calcitonin and calcitonin gene-related peptide (CGRP). The peptide is secreted from pancreatic beta cells and is thought to have an anti-insulin action. Here, we review the recently described effects of amylin on calcium homeostasis and discuss its possible role in bone conservation. Amylin is a potent hypocalcemic and antiresorptive peptide. Studies using isolated osteoclasts have revealed that amylin inhibits cell motility (Q effect), without affecting cell spread area or elevating cytosolic [Ca(2+)]. Thus, amylin action is similar to that of calcitonin, but lower in potency. Lower circulating concentrations of amylin in type-1 diabetes may cause the bone loss associated with this condition.
spellingShingle Zaidi, M
Shankar, V
Huang, C
Pazianas, M
Bloom, SR
Amylin in bone conservation current evidence and hypothetical Considerations.
title Amylin in bone conservation current evidence and hypothetical Considerations.
title_full Amylin in bone conservation current evidence and hypothetical Considerations.
title_fullStr Amylin in bone conservation current evidence and hypothetical Considerations.
title_full_unstemmed Amylin in bone conservation current evidence and hypothetical Considerations.
title_short Amylin in bone conservation current evidence and hypothetical Considerations.
title_sort amylin in bone conservation current evidence and hypothetical considerations
work_keys_str_mv AT zaidim amylininboneconservationcurrentevidenceandhypotheticalconsiderations
AT shankarv amylininboneconservationcurrentevidenceandhypotheticalconsiderations
AT huangc amylininboneconservationcurrentevidenceandhypotheticalconsiderations
AT pazianasm amylininboneconservationcurrentevidenceandhypotheticalconsiderations
AT bloomsr amylininboneconservationcurrentevidenceandhypotheticalconsiderations